Ranbaxy Laboratories Limited
May 28, 2012 at 11:26 | Source: Moneycontrol.com
May 23, 2012 at 15:00 | Source: CNBC-TV18
May 17, 2012 at 15:38 | Source: Moneycontrol.com
May 17, 2012 at 10:12 | Source: Reuters
May 15, 2012 at 15:05 | Source: Moneycontrol.com
May 11, 2012 at 15:50 | Source: CNBC-TV18
Interact & exchange stock tips & market info »
Related News »
is a U.S. based wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL). RLI is focused on the promotion of branded prescription products in the U.S. RLI has been expanding and growing on the strength of Ranbaxy's R&D efforts, and ...
May 28, 2012 at 03:28 | Source: Yahoo Finance
Wockhardt hits lifetime high, soars 14% post Q4 results 23-MAY-12 Wockhardt Limited has rallied 6% to ... points in the last three straight weeks. Ranbaxy surges on robust Q1 earnings 09-MAY-12 Ranbaxy Laboratories has moved higher by 5% at Rs 518, on ...
May 27, 2012 at 06:57 | Source: Business Standard
Pfizer Inc., Ranbaxy Laboratories Limited, Sanofi-Aventis, West Penn Allegheny Health System, Inc., F. Hoffmann-La Roche AG and Roche Diagnostics Corporation.
May 27, 2012 at 09:06 | Source: Yahoo Finance
Dr Reddy's to move away from heart diseases, diabetes 20-DEC-11 Dr Reddy’s Laboratories Limited is moving away from cardiovascular ... in the American market. Ranbaxy launches Daiichi's heart disease drug in India 10-JUN-10 Ranbaxy Laboratories today ...
May 18, 2012 at 09:31 | Source: Business Standard
Lipitor had only one independent competitor, Ranbaxy Laboratories, which owned 180-day exclusivity for Lipitor copies. The company that qualified for those rights on Plavix copies, Apotex, lost it after an at-risk launch in 2006.
May 16, 2012 at 23:59 | Source: FiercePharma
(Economic Times) PHARMACEUTICALS * Ranbaxy Laboratories plans to re-launch its former flagship ... Glenmark has chosen a strategy to capture niche segments with limited competition, such as dermatology and oral contraceptives, in the U.S ...
May 21, 2012 at 03:29 | Source: Reuters
Banks, oil & gas, steel, auto and power stocks weighed down the market while the rally in ITC and TCS has limited the downside ... assets during January-March quarter. Drug maker Ranbaxy Laboratories shot up 3.8% after it reported a better ...
May 9, 2012 at 10:10 | Source: MoneyControl.com
Ranbaxy Laboratories, India's top drugmaker ... not those of London South East Limited, or its affiliates. London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.
May 17, 2012 at 02:08 | Source: Life Style Extra